Qingyu Lin

Key Laboratory Of Science And Engineering For The Multi Modal Prevention And Control Of Major Chronic Diseases
Zhengzhou, 450000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

LISS enables immune evasion of colorectal cancers irrespective of MSI status.

LISS enables immune evasion of colorectal cancers irrespective of MSI status.

Journal: Signal transduction and targeted therapy

Published: October 01, 2025

A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophages.

A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophages.

Journal: Nature cancer

Published: June 04, 2025

A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative homeostasis in cervical cancer.

A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative homeostasis in cervical cancer.

Journal: Cancer letters

Published: April 07, 2025

Farnesylation-driven KRAS phase separation promotes colon tumor growth.

Farnesylation-driven KRAS phase separation promotes colon tumor growth.

Journal: Cell

Published: December 03, 2024

LncRNA HITT inhibits autophagy by attenuating ATG12-ATG5-ATG16L1 complex formation.

LncRNA HITT inhibits autophagy by attenuating ATG12-ATG5-ATG16L1 complex formation.

Journal: Cancer letters

Published: October 23, 2024

ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs.

ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 03, 2024

Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity.

Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity.

Journal: Cancer biology & medicine

Published: August 30, 2023

The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells.

The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells.

Journal: Cancer letters

Published: April 26, 2023

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation.

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation.

Journal: Molecular cell

Published: March 21, 2023

Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes.

Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes.

Journal: The Journal of biological chemistry

Published: July 30, 2022

iASPP suppression mediates terminal UPR and improves BRAF-inhibitor sensitivity of colon cancers.

iASPP suppression mediates terminal UPR and improves BRAF-inhibitor sensitivity of colon cancers.

Journal: Cell death and differentiation

Published: June 30, 2022

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity.

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity.

Journal: The Journal of clinical investigation

Published: June 22, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026